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Abstract 
Background: Study of age related macular degeneration (AMD) has been hampered by lack of human models that 
represent the complexity of the disease. Here we have developed a human in vitro disease model of AMD to investi-
gate the underlying AMD disease mechanisms.
Methods: Generation of iPSCs from retinal pigment epithelium (RPE) of AMD donors, age-matched normal donors, 
skin fibroblasts of a dry AMD patient, and differentiation of iPSCs into RPE (AMD RPE-iPSC-RPE, normal RPE-iPSC-RPE 
and AMD Skin-iPSC-RPE, respectively). Immunostaining, cell viability assay and reactive oxygen species (ROS) produc-
tion under oxidative stress conditions, electron microscopy (EM) imaging, ATP production and glycogen concentra-
tion assays, quantitative real time PCR, western blot, karyotyping.
Results: The AMD RPE-iPSC-RPE and AMD Skin-iPSC-RPE present functional impairment and exhibit distinct disease 
phenotypes compared to RPE-iPSC-RPE generated from normal donors (Normal RPE-iPSC-RPE). The AMD RPE-iPSC-
RPE and AMD Skin-iPSC-RPE show increased susceptibility to oxidative stress and produced higher levels of reactive 
oxygen species (ROS) under stress in accordance with recent reports. The susceptibility to oxidative stress-induced cell 
death in AMD RPE-iPSC-RPE and Skin-iPSC-RPE was consistent with inability of the AMD RPE-iPSC-RPE and Skin-iPSC-
RPE to increase SOD2 expression under oxidative stress. Phenotypic analysis revealed disintegrated mitochondria, 
accumulation of autophagosomes and lipid droplets in AMD RPE-iPSC-RPE and AMD Skin-iPSC-RPE. Mitochondrial 
activity was significantly lower in AMD RPE-iPSC-RPE and AMD Skin-iPSC-RPE compared to normal cells and glycogen 
concentration was significantly increased in the diseased cells. Furthermore, Peroxisome proliferator-activated recep-
tor gamma coactivator 1-alpha (PGC-1α), a regulator of mitochondrial biogenesis and function was repressed, and 
lower expression levels of NAD-dependent deacetylase sirtuin1 (SIRT1) were found in AMD RPE-iPSC-RPE and AMD 
Skin-iPSC-RPE as compared to normal RPE-iPSC-RPE.
Conclusions: Our studies suggest SIRT1/PGC-1α as underlying pathways contributing to AMD pathophysiology, and 
open new avenues for development of targeted drugs for treatment of this devastating neurodegenerative disease of 
the visual system.
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Background
Age related macular degeneration (AMD) is a major 
cause of blindness in the developed countries, primarily 
affects the retinal pigment epithelium (RPE) resulting in 
subsequent degeneration of the photoreceptors [1–4]. 
AMD is a multifactorial disease with a complex interac-
tion between environmental, metabolic and hereditary 
factors [5]. Clinically, AMD is presented in two forms, 
non-exudative and exudative. The non-exudative or dry 
form of AMD is diagnosed by polymorphic deposits, 
called drusen, that accumulate underneath the RPE and 
can result in overlying macular atrophy and pigmen-
tation [6]. The exudative, or wet form of AMD is char-
acterized by choroidal neovascularization leading to 
hemorrhage, retinal fluid, and eventual disciform scar 
formation [7]. However, an individual could present both 
forms at different stage of life, or initially develop dry 
form that would transform into wet form at later stage 
of the disease. To date, there is no effective treatment for 
dry AMD, yet millions of patients continue to lose their 
vision worldwide. Because of its complex etiology, under-
standing the molecular mechanisms of AMD has been 
challenging by lack of the appropriate in vitro model that 
could sufficiently recapitulate the characteristics of the 
disease. In addition, the available animal models fall short 
in accurately representing the characteristics of AMD 
due to absence of human genetic polymorphisms and 
long-term exposure to oxidative stress and environmen-
tal factors [8].
The generation of induced pluripotent stem cells 
(iPSCs) from somatic cells and their differentiation to 
various cell types offers new promise for autologous cell 
replacement therapies [9, 10]. These iPSCs also provide a 
prominent source for modeling diseases for which there 
is no adequate animal or in vitro model and may be used 
for in vitro drug screening [11]. Several groups have suc-
cessfully differentiated RPE from iPSCs [12, 13] and we 
have demonstrated that iPSC-derived RPE are pheno-
typically and functionally similar to native RPE [14], thus 
offering promise for cell replacement therapy and disease 
modeling in AMD. A recent study has associated the 
abnormal ARMS2/HTRA1 expression in iPSC-RPE from 
AMD patients with decreased SOD2 defense against oxi-
dative stress making RPE more susceptible to oxidative 
damage [15]. Another study reprogrammed T cells from 
patients with dry type AMD into iPSCs-RPE and showed 
reduced antioxidant ability in AMD RPE as compared to 
normal RPE cells [16]. Recently, dysregulated autophagy 
in RPE was associated with increased susceptibility to 
oxidative stress and AMD [17, 18]. Another study related 
the decline in clearance system to induction of inflamma-
some signaling in human ARPE-19 cell line [19]. A more 
recent study reported mtDNA damage in RPE that may 
impact mitochondrial function [20]. However, to date, 
the phenotypic characterization of AMD patient-specific 
iPSC-RPE, as well as the underlying mechanisms respon-
sible for the pathophysiology of AMD remains to be 
elucidated.
We cultured RPE from AMD and age-matched nor-
mal donors. Because primary RPE undergo senescence 
in culture by passaging, we generated iPSCs from the 
RPE of AMD and normal donor eyes with CFH, HTRA1/
ARMS2, LOC abnormal alleles, or with FACTOR B pro-
tective alleles, followed by differentiation into RPE (AMD 
RPE-iPSC-RPE and Normal RPE-iPSC-RPE) (Table  1). 
We also generated iPSCs from skin fibroblasts of a dry 
AMD patient with CFH, HTRA1/ARMS2, LOC, and 
FACTOR B risk alleles, and differentiated them into RPE 
(Skin AMD iPSC-RPE) (Table 1). This approach allowed 
us to establish an inexhaustible in vitro disease model to 
study the molecular mechanisms of AMD.
A number of retinal pathologies including AMD are 
associated with mitochondrial dysfunction [21]. Dys-
functional mitochondria induce increased levels of ROS, 
mitochondrial DNA (mtDNA) damage, and defective 
metabolic activity [22]. A major role in mitochondrial 
biogenesis and oxidative metabolism is played by per-
oxisome proliferator-activated receptor-gamma coacti-
vator (PGC)-1α (PGC-1α). Its repression contributes to 
disorders such as obesity, diabetes, neurodegeneration, 
and cardiomyopathy [23–27]. Recently DNA sequence 
variants in PPARGC1A gene coding for PGC-1α were 
reported to be associated with neovascular (NV) AMD 
and AMD-associated loci [28]. A more recent study 
reported a role for PGC-1α in induction of human RPE 
oxidative metabolism and antioxidant capacity [29]. 
PGC-1α is shown to play an important role in mitochon-
drial biogenesis and turnover [30, 31]; it also plays a role 
in autophagy/mitophagy in a manner that is specific to 
cellular metabolic state [32, 33]. In addition, PGC-1α is 
known to regulate the expression of electron transport 
chain (ETC) genes, lipid catabolism genes, and oxidative 
stress protective genes in vascular endothelial cells [34].
However, the role of PGC-1α in the pathophysiology of 
AMD remains to be elucidated. SIRT1 (silent informa-
tion regulator T1) belongs to a family of class II histone/
protein deacetylase proteins and is known as the only 
protein able to deacetylate and activate PGC-1α [35, 36]. 
SIRT1 has shown to play a major role in energy metabo-
lism in various tissues that can directly interact and regu-
late the activity of transcription factors and co-regulators 
including PGC-1α [23].
We demonstrated that iPSC-derived RPE from RPE of 
AMD donors and from skin of an AMD patient exhibit 
specific disease phenotypes and impaired functions as 
compared to iPSC-RPE generated from RPE of normal 
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donors. We sought to determine the underlying mecha-
nisms responsible for the AMD disease phenotypes that 




The eyes of organ donors clinically diagnosed with AMD 
and control organ donors were purchased from National 
Disease Research Interchange (NDRI, Philadelphia, PA). 
Eyes of donors with diabetes or other known ocular dis-
ease were excluded from the study. Eyes were enucle-
ated on average 9  h after death and were delivered in 
less than 24  h. Serology tests were performed on each 
donor by NDRI to exclude samples with potential infec-
tious diseases [37] (Table 1). RPE from macula of AMD 
donors and normal donors were isolated and cultured. 
Briefly, the posterior eyecup was dissected into four sec-
tions with a razor blade and was placed flat. The sensory 
retina was removed and the RPE-choroid layer was gently 
peeled. The RPE-choroid layer was digested by dispase, 
the RPE layer was peeled off with a forceps and filtered 
as reported previously [38]. RPE were purified with 
Magnetic-Activated Cell Sorting (MACS) by positive 
selection for epithelial cells using anti-BEST1 antibody 
(Abcam) and anti-E-cadherin (Miltenyi Biotech); and by 
negative selection using a fibroblast-specific antibody 
(Miltenyi Biotech) to remove fibroblasts. The RPE cells 
were grown in RPE Media [38] at 37 °C, with 5% O2 and 
5% CO2.
Skin biopsy of the dry AMD patient was received in 
Viaspan preservation solution by courier immediately 
after the biopsy was taken. The skin biopsy was immedi-
ately treated upon reception for fibroblast isolation based 
on an established protocol [39] using DMEM containing 
10% FBS at 37 °C, with 5% O2 and 5% CO2. Briefly, a small 
skin biopsy was incubated overnight in dispase solution. 
The next day the epidermis was peeled off with a forceps 
and the dermis was cut in small pieces and put in 24 well 
plates for fibroblasts to expand and grow as previously 
reported [39].
Single nucleotide polymorphisms (SNPs) genotyping 
of RPE and fibroblasts
RPE from AMD and normal organ donors and fibroblasts 
from the AMD patient were tested for selected SNPs 
known to be associated with AMD by RT-PCR followed 
by sequencing analysis.
Generation of iPSCs
The RPE from two AMD donors and three normal donors 
as well as fibroblasts from an AMD patient were used 
to generate iPSCs using non-integrating Sendai viruses 
according to the established protocol (CytoTune®-iPS 
Sendai Reprogramming Kits, ThermoFisher Scientific). 
The iPSCs were characterized by live staining of the colo-
nies with Tra-1-60 antibody (LifeTechnologies), and fixed 
staining with Nanog antibody (Novus Biologicals). RT- 
PCR confirmed the expression of pluripotency genes.
Differentiation of iPSCs to RPE
iPSCs were differentiated to functional RPE using the 
established protocol as previously described [14]. Briefly, 
the iPSCs were transferred to Aggrewells (Stem Cell 
Technologies; 1000–2000 cells/well) to form embryoid 
bodies (EBs) in suspension culture using Dulbecco’s mod-
ified Eagle’s medium (DMEM) with 10% serum replace-
ment, 1× nonessential amino acids, 2  mM glutamine, 
and 0.1  mM b-mercaptoethanol) for 1  day, with 10  μM 
nicotinamide (NIC; SIGMA) added the next day and sup-
plemented with 140 ng/ml recombinant human activin-A 
(R&D Systems, Minneapolis, MN, www.rndsystems.com) 
in the presence of NIC and SB431542 (SIGMA) for the 
3rd and 4th week of differentiation. Pigmented foci were 
formed after the 4th week. Differentiating clusters were 
transferred to poly-d-lysine (2 lg/cm2, BD Biosciences) 
and 4 μg/ml laminin (SIGMA), for attachment on the 6th 
week and cultured in the presence of NIC for 3–5 weeks. 
Differentiating RPE cells were also cultured on 0.4  μm 
pore polyester membrane transwells (Corning) for induc-
tion of polarization and functional studies.
Immunostaining
The iPSCs were cultured on 6-well plate laminine-coated 
dishes and stained either by live staining with Tra-1-
60 antibody (Life Technologies) or fixed staining with 
Nanong antibody (Novus Biologicals) according to the 
manufacturer protocol.
The iPSC-RPE cells were cultured on transwells in 
24-well plates and stained using primary and secondary 
antibodies as listed in the Additional file 1: Table S2. The 
iPSC-RPE were stained with anti ZO-1 antibody (Life 
Technologies), anti RPE65 (Generous gift from Dr. Red-
mond lab), anti Occludin antibody (Life Technologies), 
and anti Bestrophin antibody (Abcam) per manufacturer 
protocols. Anti-fading media were added to the cells 
before mounting onto glass slides (ThermoFisher, cat# 
P36930). Images were collected on EVOS FL microscope 
(Life Technologies) or confocal microscopy (Olympus 
Fluoview).
Quantitative reverse transcription and polymerase chain 
reaction (qRT-PCR)
RNA was extracted from samples using the RNeasy 
Mini Kit (Qiagen, Germantown, MD). Samples were 
then treated with RNase-free DNase I and reversely 
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transcribed using oligo-dT (SuperScript III cDNA syn-
thesis kit from Qiagen, cat# 74104). Primers (Additional 
file  1: Table S1) used were specifically designed with 
PrimerQuest software (Integrated DNA Technologies).
Immunobloting
IPSC-RPE cells were harvested from one well of 24 well 
plate. Cell pellets were homogenized in RIPA buffer 
by vortex every 10  min for 1  h. The homogenates were 
centrifuged at 15,000×g for 30 min at 4 °C, and the pel-
lets were discarded. The protein concentrations of the 
supernatants were determined by the Bradford assay. 
The samples were then treated with NuPAGE LDS Sam-
ple Buffer (Cat. No. NP0007, Life Technologies), dena-
tured by boiling for 5 min, and subjected to SDS-PAGE 
(NuPAGE 3–8% Tris-Acetate Gel, Cat. No. EA0378BOX, 
Invitrogen). The separated proteins were transferred to 
polyvinylidene difluoride membrane and the nonspecific 
binding sites were blocked by incubation with 5% nonfat 
dry milk in Tris buffered Saline, 0.01% Tween20 (TBST) 
for 1  h at room temperature. The membrane was then 
incubated with first antibody diluted in 5% bovine serum 
albumin (BSA)/TBST overnight at 4 °C. The β-actin anti-
body was used as a loading control. The immune-reactive 
bands were detected by Clarity Western ECL (BIO-RAD, 
cat# 1705060). Densitometry was performed using the 
ImageJ software.
Phagocytosis of photoreceptor outer segments (POSs)
Bovine rod outer segments (POSs) were purified with 
discontinuous sucrose density gradient centrifugation 
as described previously [40]. The POS pellet was labeled 
with FITC using the established protocol [41].
Fluorescent POS (5 × 106) were added in 40 μl of RPE 
media containing 2.5% sucrose to the apical surface of 
differentiated iPSC-RPE cells cultured on transwells; 
40  μl/well for 4  h. The reaction was then placed on ice 
and rinsed four times with PBS containing 1 mM MgCl2 
and 0.2  mM CaCl2 (PBS-CM). Samples were incubated 
in 0.2% Trypan blue in PBS-CM for 10  min to quench 
the reaction. Cells were fixed according to the protocol 
[41] and nuclei were labeled with DAPI. Images were col-
lected on confocal microscopy (Olympus Fluoview).
Electron microscopy
Cultured iPSC-RPE cells were first washed with Dul-
becco PBS and then fixed 2.5% glutaraldehyde in PBS (pH 
7.4) and 0.5% osmium tetroxide in PBS. The cells were 
then embedded in epoxy resin. 90 nm sections were col-
lected on 200 μM copper mesh grids and left to dry for 
24 h. The cells were then stained for uranyl acetate and 
lead citrate. JEOL JM-1010 electron microscope was used 
to view and image the cells.
Oxidative stress conditions
iPSC-RPE were cultured at 80–90% confluency in 96-well 
plates, at 37 °C with 5% O2 and 5% CO2. Oxidative stress 
was induced with different concentrations of H2O2 ranging 
from 0 to 10 mM for 24 or 48 h, followed by cell viability 
measurements. To test changes in gene expression levels 
under oxidative conditions, the iPSC-RPE were incubated 
with 0.4 mM of H2O2 for 2 h for 5 consecutive days.
Cell viability assay
iPSC-RPE monolayer cells cultured in 96-well plates were 
incubated for 30  min with PrestoBlue Reagent contain-
ing a cell–permeant compound that is blue in color and 
nonfluorescent in solution. When added to media, the 
reagent is rapidly taken up by cells. The reducing envi-
ronment within viable cells converts the reagent to an 
intensely red-fluorescent dye that can be detected by 
measuring fluorescence or absorbance (Life Technolo-
gies, cat# A13261). 6 wells were used for each sample. 
Fluorescence data were collected with 535 nm excitation 
wavelength and 612  nm emission wavelength (Ultra384 
plate reader).
Reactive oxygen species production assay
Measurements were carried out using OxiSelect™ Intra-
cellular ROS Assay Kit (Cell Biolabs, cat# STA-342). Brei-
fly, monolayers of iPSC-RPE cells were cultured in serum 
free RPE media for 20 h and then incubated for 1 h with 
1 mM of cell permeable fluorogenic probe 2′-7′ Dichloro-
dihydrofluorescin diacetate (DCFH-DA). To induce oxi-
dative stress, samples were incubated with 0.4 mM H2O2. 
The cell-permeable fluorogenic probe DCFH-DA dif-
fuses into cells and is deacetylcated by cellular esterases 
into the non-fluorescent DCFH. In the presence of ROS, 
DCFH is rapidly oxidized to highly fluorescent DCF (Cell 
Biolabs, cat# STA-342). Tecan (Morrisville, NC) Ultra 
384 plate reader measured the fluorescence intensity of 
each sample (which is proportional to ROS levels) against 
a standard for each given time point. Excell was used to 
calculate the ROS levels.
Mitochondrial activity assay
ATP levels were used to assay the mitochondrial activi-
ties. Samples were incubated for 2  h with 10uM of 
bromopyruvate analogue (3-BrPA) (EMD Millipore, cat# 
376817), an inhibitor of glycolytic hexokinase II enzyme. 
Measurements were collected with Mitochondrial Tox-
Glo Assay that is based on the differential measurement 
of biomarkers associated with changes in cellular ATP 
levels relative to vehicle-treated controls. The results are 
collected with bioluminescent readouts. Bioluminescent 
signal is proportional to ATP concentration (Promega, 
cat# G8000).
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Cytoplasmic glycogen concentration assay
Cytoplasmic glycogen levels were assayed using the Gly-
cogen Assay Kit (Sigma, cat# MAK016) on iPSC-RPE 
monolayers grown in 96-well plates. Six wells were used 
for each sample. Glycogen concentration was determined 
by a coupled enzyme assay, which produces a colorimet-
ric (570  nm)/fluorometric (535/587  nm) product, pro-
portional to the glycogen present.
G-band karyotyping of iPSC-RPE
G-band karyotyping of the iPSCs was performed accord-
ing to the established protocol [42]. The iPSC-RPE were 
cultured in 25 cm2 dishes and prepared for karyotyping.
Results
Generation of functional iPSC-derived RPE
To investigate the molecular and cellular mechanisms of 
AMD, we generated iPSCs from RPE of AMD and age-
matched normal donor eyes (RPE-iPSCs) and from skin 
fibroblasts of a dry AMD patient (Skin-iPSCs) (Table 1). 
While primary RPE could be used to study the disease 
phenotypes in AMD, they can quickly become depleted 
due to passaging and undergo senescence, whereas, 
iPSCs can serve as an inexhaustible source that could 
continuously be differentiated to the RPE for mainte-
nance of the disease model.
We purified and cultured the RPE isolated from the 
macular region of the human eyes according to the estab-
lished protocol [38] and performed the genetic study 
of the single nucleotide polymorphisms (SNPs) for the 
known AMD susceptibility loci. Table 1 summarizes the 
age, gender, and genetic characteristics of the cultured 
RPE from donors and the skin fibroblasts of an AMD 
patient. As shown in Table 1, the control RPE #010 exhib-
its SNPs for known AMD susceptibility loci, however the 
donor did not present AMD at 80  years old. Moreover, 
the AMD RPE #009 with a history of long-term heavy 
smoking while exhibiting the protective alleles, presented 
AMD pathology. This further reinforces that in addition 
to genetic background, environmental and epigenetic 
factors also play important roles in the etiology of AMD 
and that the susceptibility alleles are not the sole contrib-
utors to the disease.
For generation of iPSCs we used non-integrating Sen-
dai viruses. The generated iPSC colonies were manually 
picked and expanded and were characterized by staining 
with Tra1-60 and Nanog (Additional file  1: Figure S1A) 
as well as by Real-Time PCR for pluripotency markers 
(Additional file  1: Figure S1B). To verify that the iPSCs 
do not present chromosomal abnormalities, karyotyp-
ing was performed on all generated iPSC lines. G band 
karyotyping analyses are presented in Additional file  1: 
Figure S2. As shown in Additional file  1: Figure S2, all 
tested cells for the AMD RPE-iPSC-RPE and the AMD 
Skin-iPSC-RPE with female background present normal 
karyotyping with XX chromosomes (9R, 32R and 005BF). 
The healthy RPE-iPSC-RPE with male background 
were normal for all somatic chromosomes, however, in 
approximately 50% of the tested cells the Y chromosome 
was missing. It is known that loss of the Y chromosome 
in males is a phenomenon associated with aging [43], and 
it is quite probable that the donors presented aneuploidy 
prior to sample collections. This is further supported by 
reports showing that the predominant genetic changes 
found in hiPSC lines involve changes in chromosomes 
1, 12, 17 and 20, reminiscent of the changes observed in 
cancer cells [44].
The iPSCs were differentiated into functional RPE 
as previously described [14], and the generated iPSC-
RPE cell lines were characterized by immunostaining 
with ZO-1, RPE65, Occludin and Bestrophin antibodies 
(Fig.  1a). Our data showed that all iPSC-RPE cell lines 
were positive for the above staining and were character-
ized as RPE.
We also performed real-time PCR for RPE signature 
genes with iPSC-RPE and their parental donors the pri-
mary RPE. All iPSC-RPE expressed the RPE specific 
genes comparable to the primary RPE from which they 
were derived (Fig. 1b,c).
To confirm the functionality of the iPSC-RPE we per-
formed phagocytosis assay by incubating the iPSC-RPE 
with bovine photoreceptor outer segments (POS) that 
were conjugated with FITC. We quenched the uninter-
nalized POS by treating the samples with Trypan blue to 
only visualize the internalized POS. Figure  2 shows the 
POS phagocytosis in iPSC-RPE cultured on transwells for 
4 weeks, and reveal that all cell lines are functional, capa-
ble of phagocytosing the POS. A representative image for 
normal and AMD samples with and without Trypan blue 
treatment is shown in Additional file 1: Figure S3.
Identification of distinct functional impairments in AMD 
RPE-iPSC-RPE and AMD Skin-iPSC-RPE
We have differentiated the AMD and normal RPE-iPSCs, 
and AMD Skin-iPSC to functional RPE, we then inves-
tigated their phenotypic and functional characteristics . 
Interestingly, both AMD RPE-iPSC-RPE and AMD Skin-
iPSC-RPE demonstrated similar disease-relevant cellular 
phenotypes, whereas, the normal RPE-iPSC-RPE were 
devoid of disease phenotypes, and presented normal cel-
lular and molecular characteristics (Figs. 3, 4). 
We performed several cellular and molecular assays. 
First, we verified the cell viability of the AMD RPE-iPSC-
RPE and AMD Skin-iPSC-RPE as compared to nor-
mal iPSC-RPE under oxidative stress conditions that we 
have established in our lab by incubating the RPE under 
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Fig. 1 Differentiation and characterization of iPSC-RPE. a Immunostaining of the iPSC-RPE cultured on transwells for 4 weeks with ZO-1 antibody, 
RPE65, Occludin, and Bestrophin. Scale bar represent 100 μM. b Graph illustrating RPE specific gene expressions in differentiated iPSC-RPE cell lines. 
c RPE specific gene expression in native RPE from which the iPSC-RPE are generated. Relative expression of each gene to GAPDH is compared to its 
relative expression level in control iPSC-RPE
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increasing concentration of H2O2 for 48  h. Cell viability 
assay under oxidative stress conditions revealed that the 
AMD RPE-iPSC-RPE and AMD Skin-iPSC-RPE show 
increased susceptibility to oxidative stress and present 
higher levels of cell death at 0.1, 0.2 and 0.4 mM of H2O2 
when compared to normal RPE-iPSC-RPE under the same 
conditions (Fig. 3a).
To test whether the AMD RPE-iPSC-RPE and AMD 
Skin-iPSC-RPE exhibit increased reactive oxygen species 
(ROS) production, we quantified the ROS production in 
AMD RPE-iPSC-RPE and AMD Skin-iPSC-RPE com-
pared to normal iPSC-RPE in the presence of 0.4 mM of 
H2O2 for 0, 5, 15, 30 min and 1 h incubation. Our results 
shown in Fig. 3b revealed that AMD RPE-iPSC-RPE and 
AMD Skin-iPSC-RPE produce significantly higher levels 
of ROS under oxidative stress conditions as compared to 
normal RPE-iPSC-RPE.
These observations are in accordance with the results 
showed by Chang et  al. [16]. We also demonstrate that 
both AMD RPE-iPSC-RPE and AMD Skin-iPSC-RPE 
exhibit the disease relevant cellular phenotype and could 
be used for in vitro disease modeling in AMD.
Super oxide dismutases (SODs) provide defense against 
ROS and plays an important role in controlling oxidative 
stress [45]. To investigate the involvement of ARMS2/
HTRA1 in affecting the SOD2 defense in RPE as reported 
by Yang et  al., we measured the expression levels of 
superoxide dismutase 2 (SOD2) in AMD RPE-iPSC-RPE 
and AMD Skin-iPSC-RPE compared to normal RPE-
iPSC-RPE by Real-Time PCR under normal and our 
established chronic stress conditions by incubation of the 
cells for 2 h with H2O2 at 0.4 mM for 5 consecutive days.
Our data showed that only the normal RPE-iPSC-RPE 
cells harboring either abnormal ARMS2/HTRA1 allele 
Fig. 2 Phagocytosis assay in iPSC-RPE. Phagocytosis assay on iPSC-RPE cultured on transwells for 4 weeks representing internalized FITC-conju-
gated POS. The reaction was quenched with Trypan blue to mask uninternalized POS. Nuclei are represented in blue by DAPi staining. Scale bar 
represent 100 μM
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(6R, 10R) or normal ARMS2/HTRA1 allele (25R) were 
able to increase the SOD2 expression during stress con-
ditions, whereas the SOD2 expression levels were not 
increased in AMD RPE-iPSC-RPE and AMD Skin-iPSC-
RPE with abnormal ARMS2/HTRA1 allele (32R, 005BF), 
or in AMD RPE-iPSC-RPE with normal ARMS2/HTRA1 
and protective Factor B alleles (9R, a heavy smoker 
donor) under the same conditions (Fig.  4a). This inabil-
ity to increase the SOD2 levels under stress conditions 
correlates with the increased susceptibility to oxidative 
stress-induced cell death observed in the AMD RPE-
iPSC-RPE and AMD Skin-iPSC-RPE (Fig.  3a). These 
observations further suggest that besides the AMD risk 
alleles, other unknown factors such as genetic, environ-
mental, or epigenetic factors may play a role in regulating 
SOD2 defense levels and in AMD pathophysiology.
It has been reported that damaged mitochondria leads 
to increased ROS production by the cells [46]. Since 
SOD2 is a mitochondrial protein that plays an important 
role in antioxidant defense, we sought to investigate the 
mitochondrial activity in AMD RPE-iPSC-RPE and AMD 
Skin-iPSC-RPE. The mitochondrial activity was evalu-
ated by measurement of ATP production in the pres-
ence and absence of hexokinase inhibitor that inhibits 
the ATP produced by glycolysis. Our data showed that 
ATP production in the presence of hexokinase inhibitor 
that solely represents mitochondrial ATP production, 
was significantly reduced in AMD RPE-iPSC-RPE and 
AMD Skin-iPSC-RPE compared to normal RPE-iPSC-
RPE (Fig. 4b); whereas, the total ATP production in the 
absence of hexokinase inhibitor was higher in AMD RPE-
iPSC-RPE and AMD Skin-iPSC-RPE compared to nor-
mal RPE-iPSC-RPE, suggesting that the majority of ATP 
in the AMD RPE-iPSC-RPE and AMD Skin-iPSC-RPE is 
produced by glycolysis (Fig. 4c).
Enhanced glycogenesis is associated with cellular 
senescence [47] and glycogen accumulation occurs in 
diverse cellular senescence models [47]. To test whether 
glycogen accumulation is a cellular phenotype in AMD 
RPE-iPSC-RPE and AMD Skin-iPSC-RPE, we deter-
mined the cellular glycogen concentration. Interestingly, 
glycogen concentration was significantly higher in AMD 
RPE-iPSC-RPE and AMD Skin-iPSC-RPE when com-
pared to normal RPE-iPSC-RPE (Fig. 4d).
The susceptibility to oxidative stress, higher levels of 
ROS, increased glycogen concentration and inability 
of AMD RPE-iPSC-RPE and AMD Skin-iPSC-RPE to 
increase antioxidant defense can be explained by dys-
functional mitochondria observed in our AMD iPSC-
RPE cells.
Identification of disease-relevant cellular phenotypes 
in AMD RPE-iPSC-RPE and AMD Skin-iPSC-RPE
Our data from functional assays lead us to phenotypi-
cal analysis of the AMD RPE-iPSC-RPE and AMD Skin-
iPSC-RPE compared to normal iPSC-RPE. Figure  5a–f 
show the electron microscopy imaging (EM) of the dis-
eased and normal iPSC-RPE. As shown in Fig.  5, the 
AMD RPE-iPSC-RPE (b, f ) and AMD Skin-iPSC-RPE 
(d) appear to have disintegrated mitochondria, increased 
Fig. 3 AMD iPSC-RPE exhibit increased susceptibility to oxidative stress and produce higher ROS. a Cell viability assays of AMD and control iPSC-RPE 
treated with increasing concentrations of H2O2 for 48 h. Higher susceptibility to oxidative stress-induced cell death under oxidative stress conditions 
(0.1, 0.2 and 0.4 mM H2O2) is observed in AMD RPE-iPSC-RPE (9R, 32R) and AMD Skin-iPSC-RPE (005BF) as compared to normal RPE-iPSC-RPE (6R, 
10R, 25R). b ROS production under stress conditions is significantly higher in AMD RPE-iPSC-RPE (9R, 32R) and AMD Skin-iPSC-RPE (005BF) as com-
pared to normal RPE-iPSC-RPE (6R, 10R, 25R). Asterisk (*) in a and b indicates statistically significant difference between control and AMD iPSC- RPE, 
determined by student t test, p ≤ 0.05
Page 10 of 17Golestaneh et al. J Transl Med  (2016) 14:344 
number of autophagosomes and higher levels of cyto-
plasmic lipid accumulation (f ) as compared to normal 
RPE-iPSC-RPE (a, c, e).
Dry AMD is characterized by accumulation of lipid 
deposits called drusen between the RPE and Bruch’s 
membrane [6]. In addition, mitochondrial dysfunction is 
shown to induce formation of lipid droplets as a response 
to stress [48, 49]. Therefore, accumulation of lipid drop-
lets in AMD-iPSC-RPE could reflect a disease-relevant 
cellular phenotype. These phenotypic observations cor-
relate with the susceptibility of the AMD iPSC-RPE to 
oxidative stress, higher production of the ROS and inabil-
ity of the AMD iPSC-RPE to increase SOD2 levels under 
the stress conditions and reduced mitochondrial activity 
in AMD iPSC-RPE.
Repressed SIRT1/PGC-1α pathway in AMD RPE-iPSC-RPE 
and AMD Skin-iPSC-RPE
Based on our observations on mitochondrial disinte-
gration (Fig.  5b–f) and dysfunction (Fig.  4b, c), and 
the reduced ability to induce SOD production under 
oxidative stress in AMD RPE-iPSC-RPE and AMD 
Fig. 4 AMD iPSC-RPE express lower SOD2 defense, lower mitochondrial activity and present higher cytoplasmic glycogen concentration. a AMD 
RPE-iPSC-RPE and AMD Skin-iPSC-RPE are not capable of increasing SOD2 expression under stress conditions as compared to normal RPE-iPSC-
RPE. AMD and control iPSC-RPE were treated with 0.4 mM H2O2 for 2 h for 5 consecutive days after which RNA were extracted and analyzed via 
quantitative RT-PCR. As opposed to normal RPE-iPSC-RPE (6R, 10R, 25R), the AMD RPE-iPSC-RPE (9R, 32R) and AMD Skin-iPSC-RPE (005BF) were not 
responsive to stress conditions and did not increase the SOD2 gene expression under stress conditions. GAPDH was used to normalize the samples 
and the relative expression of each sample is compared. Asterisks (*) in a indicate statistical significance, determined by student t test (p ≤ 0.05).  
b, c AMD iPSC-RPE have significantly lower mitochondrial activity as compared to control iPSC-RPE, as indicated by ATP levels measured by a lumi-
nescence assay in the presence (b) and absence (c) of hexokinase inhibitor. Asterisks (***) in b and c show significance analyzed by Anova followed 
by Tukey, p ≤ 0.0001. d Measurement of cytoplasmic glycogen accumulation by colorimetric assay showing higher concentration in AMD iPSC-RPE 
as compared to control iPSC-RPE. Asterisks (****) in d show significance analyzed by Anova followed by Tukey, p ≤ 0.0001
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Fig. 5 AMD iPSC-RPE exhibit relevant cellular phenotypes. a–f Representative electron microscopy images of normal (a 25R; c10R; e 25R), AMD-
RPE-iPSC-RPE (b 32R; f 9R) and AMD Skin iPSC-RPE (d 005BF) showing diseased phenotypes. Red arrows indicate the observed morphological 
differences. Higher magnification insets show disintegrated mitochondria (in b 32R), in comparison with the normal mitochondria (in a 25R). M 
mitochondria, DM disintegrated mitochondria, LD lipid droplets, AP autophagosomes. All scale bars represent 500 nm
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Skin-iPSC-RPE (Fig.  4a), we sought to investigate the 
implication of the pathways regulators of mitochondrial 
biogenesis and functions. We first tested the expression 
of PGC-1α by real time PCR. While PGC-1α gene expres-
sion could vary from sample to sample, we observed a 
general trend of reduced PGC-1α exression levels in our 
AMD RPE-iPSC-RPE and AMD-Skin-iPSC-RPE as com-
pared to normal RPE-iPSC-RPE (Fig. 6a).
Since SIRT1 acts upstream of PGC-1α and regultaes 
PGC-1α activity [50], we next analyzed the SIRT1 pro-
tein expression by western blot analysis in all generated 
cells lines. Our data showed a decrease in SIRT1 protein 
levels in AMD RPE-iPSC-RPE and AMD-Skin-iPSC-RPE 
as compared to normal RPE-iPSC-RPE (Fig.  6b). Den-
sitmetry analysis of three independent experiements 
showed ≅twofold decrease in SIRT1 protein in our AMD 
RPE-iPSC-RPE and AMD Skin-iPSC-RPE as compared 
to normal RPE-iPSC-RPE (Fig. 6c).
These observations suggest dysfunctional SIRT1/
PGC-1α pathway as the underlying mechanisms con-
tributing to AMD pathophysiology and correlate with 
the disease cellular phenotypes that we observed in our 
AMD iPSC-RPE.
Discussion
AMD is a complex multifactorial disease that is caused 
by contribution of genetic, metabolic and environmental 
factors. Millions of people worldwide are suffering from 
AMD and the prevalence of the disease is expected to 
double by 2050 [51]. The molecular mechanisms of AMD 
remain poorly understood due to the lack of a human 
in  vitro model that exhibits the characteristic of the 
Fig. 6 Reduced SIRT1 protein levels and PGC-1 expression in AMD-iPSC-RPE. a Quantitative real time PCR showing decreased PGC-1 expression in 
AMD-iPSC-RPE as compared to normal iPSC-RPE. Graph represents mean ± SE of three independent experiments. Asterisk (****) show statistically 
significance analyzed by Anova followed by Tukey, p ≤ 0.0001. b Representative western blot image of three independent experiments showing 
SIRT1 protein levels in iPSC-RPE. B-actin was used as normalization control. c Densitometry of average of three independent western blots showing 
≅twofold decrease in SIRT1 protein levels in AMD RPE-iPSC-RPE and AMD Skin-iPSC-RPE as compared to normal RPE-iPSC-RPE. Asterisks (*) in c show 
significance analyzed by Anova followed by Tukey, p ≤ 0.05
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disease. While several animal models are being studied, 
they do not fully recapitulate the complex multifactorial 
aspects of AMD. Moreover, the single nucleotide poly-
morphisms and life-long exposure to oxidative stress in 
human make the study of AMD even more challenging.
The iPSC technology has become a revolutionized 
method to model diseases for which there is no adequate 
human in vitro model. While iPSC-derived disease mod-
els have been successfully generated and characterized in 
monogenic diseases, generation of in vitro disease mod-
els with significant cellular phenotypes in multifactorial 
diseases has been less successful [11, 52]. Several stud-
ies have shown that iPSC retain the epigenetic memory 
of their tissue of origin [53–57], while environmental 
and epigenetic causes of diseases are erased by repro-
gramming [52]. Another study by Hu et al. has reported 
that reprogrammed human RPE cells show tendency for 
spontaneous redifferentiation  into RPE, suggesting that 
the epigenetic memory is retained in iPSCs [54]. These 
observations suggest that RPE-iPSC-RPE might be supe-
rior to Skin-iPSC-RPE for AMD disease modeling. To 
address this point, here we have generated iPSCs from 
RPE of macular region of healthy donors and donors 
clinically diagnosed with AMD, and from skin biopsy of 
a dry AMD patient, followed by differentiation into RPE. 
We then characterized them and performed functional 
studies. Our data revealed that both cell types exhibit 
similar disease relevant phenotypes and are prominent 
sources for AMD disease modeling. We demonstrate that 
patient-specific iPSC-RPE exhibit distinct disease phe-
notypes compared to normal iPSC-RPE and could be an 
excellent source for disease modeling and for develop-
ment of new treatments for AMD. However, these find-
ings should be taken into consideration prior to attempts 
for autologous cell transplantation in AMD.
We observed relevant disease phenotypes, such as 
susceptibility to oxidative stress and increased levels of 
ROS formation in accordance with the recently reported 
data [16]. We also observed lower SOD2 defense in 
AMD iPSC-RPE with abnormal ARMS2/HTRA1 expres-
sion concomitant with the recent report by Yang et  al. 
[15]. However, we also found that the iPSC-RPE gener-
ated form RPE of normal donor harboring abnormal 
ARMS2/HTRA1 expression (Table  1), had the ability to 
increase SOD2 expression under oxidative stress condi-
tion, whereas the AMD iPSC-RPE generated from RPE 
of AMD donor with normal ARMS2/HTRA1 and with 
protective FACTOR B allele but with a history of heavy-
smoking presented reduced ability to increase SOD2 
levels under the same stress conditions. These observa-
tions further support the multifactorial origin of AMD 
and suggest that the susceptibility alleles may not be the 
sole contributor to lowered SOD2 defense and support 
our observations that repressed PGC-1α/SIRT1 pathway 
could contribute to AMD pathophysiology.
Mitochondria is known to be the major source of ROS 
production and an excess of ROS can induce mitochon-
drial damage and lead to diseases [58, 59]. Mitochon-
drial dysfunction is reported to induce formation of lipid 
droplets as a generalized response to stress [48], and to 
cause a reduction in mitochondrial oxidative and phos-
phorylation activity [60]. We therefore measured mito-
chondrial activity in AMD RPE-iPSC-RPE and AMD 
Skin-iPSC-RPE and compared it to normal iPSC-RPE-
RPE. Our data revealed decreased ATP production by 
mitochondria and increased ATP production by gly-
colysis in AMD RPE-iPSC-RPE and AMD Skin-iPSC-
RPE compared to normal RPE-iPSC-RPE. This finding 
suggests glycolysis as the major source of ATP produc-
tion in AMD RPE-iPSC-RPE and AMD Skin-iPSC-
RPE. While ATP is the major source of cellular energy, 
elevated levels of ATP can inhibit AMP-activated pro-
tein kinase (AMPK), a key energy sensor that regulates 
cellular metabolism and autophagy [61, 62]. This could 
explain the accumulation of autophagosomes that we 
observed in AMD RPE-iPSC-RPE and AMD Skin-iPSC-
RPE, which indicates inhibition of autophagic dynamics, 
and accumulation of unwanted and undigested materials 
in the cells.
Phenotypic analysis by EM revealed disintegrated 
mitochondria, accumulation of autophagosomes and 
lipid droplets in AMD RPE-iPSC-RPE and AMD Skin-
iPSC-RPE. In accordance with our observations, another 
group reported that drusen in AMD donor eyes sections 
contained increased levels of autophagic markers [63]. 
Moreover, dysregulated autophagy in RPE was recently 
associated with increased susceptibility to oxidative 
stress, and AMD [17, 18]. A recent study also reported 
increased flavoprotein fluorescence in nonexudative 
eyes with AMD, proposing mitochondrial dysfunction in 
AMD [64].
The RPE is constantly exposed to light-induced oxida-
tive damage and oxidative stress has been proposed as 
an important factor in contributing to the development 
of AMD [4, 65]. Nonetheless, the mechanisms underlying 
the susceptibility to oxidative stress in AMD remains to 
be elucidated.
PGC-1α plays a major role in mitochondrial biogenesis 
and oxidative metabolism [66]. Its repression is associ-
ated with obesity, diabetes, neurodegeneration, and car-
diomyopathy disorders [23–27]. A role for PGC-1α in 
determining light damage susceptibility and regulating 
normal and pathological angiogenesis in the retina has 
also been reported [24, 67]. A recent study proposed a 
role for PGC-1α in induction of human RPE oxidative 
metabolism and antioxidant capacity [29]. However, to 
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date the role of PGC-1α in the pathophysiology of AMD 
is largely unknown.
To investigate the underlying mechanisms related to 
the observed phenotypes in our cells, we analyzed the 
PGC-1α expression. Our data showed lower PGC-1α 
expression in AMD iPSC-RPE cells compared to normal 
iPSC-RPE in accordance with the phenotypic disease 
state of the cells.
We further analyzed SIRT1 expression in AMD iPSC-
RPE and normal iPSC-RPE. Accordingly, SIRT1 protein 
levels were reduced in the AMD RPE-iPSC-RPE and 
AMD Skin-iPSC-RPE as compared to normal RPE-iPSC-
RPE. SIRT1 is known to directly affect PGC-1α activity 
through phosphorylation and deacetylation [23]. It is also 
know that AMPK activation increases PGC-1α expres-
sion, and activates PGC-1α by direct phosphorylation 
[68]. AMPK activation also induces SIRT1-mediated 
PGC-1α deacetylation [69]. AMPK activation is trig-
gered by increases in cellular AMP/ATP ratio [61]. Inac-
tive AMPK results in lower autophagy dynamics causing 
accumulation of lipids and unwanted materials in the 
cells. Inactive AMPK also induces PGC-1α inactivation 
and results in lower mitochondrial biogenesis and turno-
ver affecting mitochondrial activity. Increased total ATP 
caused by glycolysis that we observed in the AMD iPSC-
RPE cells could result in AMPK inactivation and con-
sequently lower the PGC-1α expression and activation. 
Based on our observations we hypothesize that repressed 
AMPK / SIRT1 / PGC-1α pathway could affect mito-
chondrial biogenesis and remodeling, causing increased 
ROS production, leading to RPE and retinal degeneration 
in AMD. Figure 7, summarizes our hypothesis.
Our data suggest involvement of SIRT1/PGC-1α path-
way in the pathophysiology of AMD and open new ave-
nues for development of novel and targeted drugs for 
treatment of AMD.
Conclusions
Our study identified morphological and functional dif-
ferences between normal iPSC-RPE and AMD iPSC-
RPE generated from RPE of healthy donors and RPE of 
donors with AMD. We also observed that the iPSC-RPE 
generated from skin biopsy of a dry AMD patient exhibit 
the same disease cellular phenotypes and therefore can 
be used for in  vitro disease modeling. The morpho-
logical changes observed in AMD RPE-iPSC-RPE and 
Skin-iPSC-RPE consist of disintegrated mitochondria, 
increased numbers of autophagosomes, and lipid drop-
lets. We further performed functional analyses of AMD 
RPE-iPSC-RPE and AMD Skin-iPSC-RPE and observed 
increased susceptibility to oxidative stress, higher ROS 
production under oxidative stress, decreased mitochon-
drial activity, inability to increase SOD2 expression under 
oxidative stress conditions, and higher cytoplasmic gly-
cogen as compared to normal RPE-iPSC-RPE. In addi-
tion, we observed lower SIRT1 levels and lower PGC-1α 
expression in AMD iPSC-RPE as opposed to normal 
iPSC-RPE.
In summary, our study suggests that repressed SIRT1/
PGC-1α causing impaired mitochondrial activity in RPE 
as responsible mechanisms for the disease cellular phe-
notypes that we observed in AMD RPE. Our data pro-
vide new insight in molecular mechanisms of AMD and 
could be used for development of potential therapeutic 
interventions.
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